These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15808545)

  • 21. Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.
    Severino ME; Laulis MK; Horwitz LR; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):520-3. PubMed ID: 8438399
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
    Hess AD; Horwitz LR; Laulis MK
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
    [No Abstract]   [Full Text] [Related]  

  • 23. Rejection of an MHC class II negative tumor following induction of murine syngeneic graft-versus-host disease.
    Bryson JS; Jennings CD; Lowery DM; Carlson SL; Pflugh DL; Caywood BE; Kaplan AM
    Bone Marrow Transplant; 1999 Feb; 23(4):363-72. PubMed ID: 10100580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo reactivity of T cell clones isolated from mice with syngeneic graft-versus-host disease.
    Bryson JS; Lake-Bullock H; Pflugh DL; Jennings CD; Stuart PM; Caywood BE; Kaplan AM
    Transplantation; 1995 Jul; 60(2):171-8. PubMed ID: 7624959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD.
    Miura Y; Thoburn CJ; Bright EC; Chen W; Nakao S; Hess AD
    Blood; 2002 Oct; 100(7):2650-8. PubMed ID: 12239181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease.
    Sugimoto K; Murata M; Terakura S; Naoe T
    J Immunol; 2009 Nov; 183(9):5991-8. PubMed ID: 19812210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of murine syngeneic graft-versus-host disease by cells of recipient origin.
    Brandon JA; Jennings CD; Perez J; Caywood B; Alapat D; Kaplan AM; Bryson JS
    Transplantation; 2007 Jun; 83(12):1620-7. PubMed ID: 17589346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
    Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute graft-versus-host disease does not require alloantigen expression on host epithelium.
    Teshima T; Ordemann R; Reddy P; Gagin S; Liu C; Cooke KR; Ferrara JL
    Nat Med; 2002 Jun; 8(6):575-81. PubMed ID: 12042807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide participates in the intestinal pathology associated with murine syngeneic graft-versus-host disease.
    Flanagan DM; Jennings CD; Goes SW; Caywood BE; Gross R; Kaplan AM; Bryson JS
    J Leukoc Biol; 2002 Oct; 72(4):762-8. PubMed ID: 12377946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.
    Hess AD; Horwitz LR; Laulis MK; Fuchs E
    Clin Immunol Immunopathol; 1993 Dec; 69(3):341-50. PubMed ID: 7694818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice.
    Flanagan DL; Gross R; Jennings CD; Caywood BE; Goes S; Kaplan AM; Bryson JS
    J Leukoc Biol; 2001 Dec; 70(6):873-80. PubMed ID: 11739549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related factors in cyclosporine-induced syngeneic graft-versus-host disease: regulatory role of marrow-derived T lymphocytes.
    Fischer AC; Hess AD
    J Exp Med; 1990 Jul; 172(1):85-94. PubMed ID: 2358786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD.
    Weston LE; Geczy AF; Briscoe H
    Bone Marrow Transplant; 2006 Jan; 37(2):207-12. PubMed ID: 16284610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adoptive transfer of murine syngeneic graft-vs.-host disease by CD4+ T cells.
    Bryson JS; Jennings CD; Brandon JA; Perez J; Caywood BE; Kaplan AM
    J Leukoc Biol; 2007 Dec; 82(6):1393-400. PubMed ID: 17726153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporin A induces a selective, reversible suppression of T-helper lymphocyte regeneration after syngeneic bone marrow transplantation: association with syngeneic graft-versus-host disease in rats.
    Bos GM; Majoor GD; van Breda Vriesman PJ
    Clin Exp Immunol; 1988 Dec; 74(3):443-8. PubMed ID: 2976623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease.
    Hess AD; Thoburn CJ
    Immunol Rev; 1997 Jun; 157():111-23. PubMed ID: 9255625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantation.
    Song J; Ito T; Matsuda C; Miao G; Tanemura M; Nishida T; Nozawa M; Matsuda H; Sawa Y
    Clin Exp Immunol; 2006 Oct; 146(1):85-92. PubMed ID: 16968402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of OX40 gene expression in graft-versus-host disease.
    Miura Y; Thoburn CJ; Bright EC; Arai S; Hess AD
    Transplant Proc; 2005; 37(1):57-61. PubMed ID: 15808546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.